Novavax, Inc. - Company Profile and SWOT Analysis, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Novavax, Inc. (Novavax or ‘the company’) is a biotechnology company that discovers, develops and markets vaccines for the prevention of serious infectious diseases. The company’s major offerings include various vaccine candidates against respiratory syncytial virus (RSV), seasonal influenza, R21 and the Ebola virus. Novavax markets vaccine candidates under Novavax, ResVax, Resolve, Prepare, Matrix, and NanoFlu brand names. It uses innovative proprietary recombinant nanoparticle vaccine technologies to develop various vaccines related to emerging disease threats. The company also develops various adjuvant formulations through Matrix-M technology. It operates manufacturing facilities in Gaithersburg, Maryland, and Uppsala, Sweden. The company is headquartered in Gaithersburg, Maryland, the US.Scope
- Detailed information on Novavax, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Novavax, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Novavax, Inc. including a breakdown and examination of key business segments
- Intelligence on Novavax, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Novavax, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Novavax, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Novavax, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Novavax, Inc.'s business structure, strategy and prospects.
Table of Contents
- Company Snapshot
- Novavax, Inc.: Company Overview
- Novavax, Inc.: Overview and Key Facts
- Novavax, Inc.: Overview
- Novavax, Inc.: Key Facts
- Novavax, Inc.: Key Employees
- Novavax, Inc.: Key Employee Biographies
- Novavax, Inc.: Major Products and Services
- Novavax, Inc.: Management Statement
- Novavax, Inc.: Locations and Subsidiaries
- Novavax, Inc.: Key Competitors
- Novavax, Inc.: Company Analysis
- Novavax, Inc.: Business Description
- Novavax, Inc.: SWOT Analysis
- Novavax, Inc.: SWOT Overview
- Novavax, Inc.: Strengths
- Novavax, Inc.: Weaknesses
- Novavax, Inc.: Opportunities
- Novavax, Inc.: Threats
- Novavax, Inc.: Corporate Financial Deals Activity
- Novavax, Inc.: Financial Deals Overview
- Novavax, Inc.: Targets and Partners
- Novavax, Inc.: Top Deals 2020 - 2024YTD*
- Novavax, Inc.: Advisors
- Novavax, Inc.: Top Legal Advisors
- Novavax, Inc.: Top Financial Advisors
- Novavax, Inc.: Mergers and Acquisitions
- Novavax, Inc.: Capital Raising
- Novavax, Inc.: Partnership
- Novavax, Inc.: Private Equity and Ownership
- Novavax, Inc.: Recent Developments
- Novavax, Inc.: News and Events Summary
- Novavax, Inc.: Business Expansion
- Novavax, Inc.: Contracts
- Novavax, Inc.: Financial Deals
- Novavax, Inc.: Market Developments
- Novavax, Inc.: Regulatory and Legal Events
- Novavax, Inc.: Research & Development
- Appendix
- Contact the Publisher
- Methodology
- About the Publisher
- Table 1: Novavax, Inc.: Key Facts
- Table 2: Novavax, Inc.: Key Employees
- Table 3: Novavax, Inc.: Locations and Subsidiaries
- Table 4: Novavax, Inc.: Key Competitors
- Table 5: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Table 6: Novavax, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Table 7: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
- Table 8: Novavax, Inc.: Targets and Partners
- Table 9: Novavax, Inc.: Top Deals 2020 - 2024YTD*
- Table 10: Novavax, Inc.: Legal Advisor Ranking by Value (US$m)
- Table 11: Novavax, Inc.: Financial Advisor Ranking by Value (US$m)
- Table 12: Novavax, Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Table 13: Novavax, Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Table 14: Novavax, Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Table 15: Novavax, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Table 16: Novavax, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Table 17: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Table 18: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
- Table 19: Novavax, Inc.: News and Events Summary
- Table 20: Novavax, Inc.: Business Expansion
- Table 21: Novavax, Inc.: Contracts
- Table 22: Novavax, Inc.: Financial Deals
- Table 23: Novavax, Inc.: Market Developments
- Table 24: Novavax, Inc.: Regulatory and Legal Events
- Table 25: Novavax, Inc.: Research & Development
- Figure 1: Novavax, Inc.: Deal Activity by Deal Type - Volume (TTM*)
- Figure 2: Novavax, Inc.: Deal Activity by Deal Type - Volume (2020 - YTD*2024)
- Figure 3: Novavax, Inc.: M&A Average Deal Size - Value (US$m)
- Figure 4: Novavax, Inc.: M&A Volume and Value Trend (2020 - YTD*2024)
- Figure 5: Novavax, Inc.: Capital Raising Volume and Value Trend (2020 - YTD*2024)
- Figure 6: Novavax, Inc.: Capital Raising by Deal Type (2020 - YTD*2024)
- Figure 7: Novavax, Inc.: Partnership Volume and Value Trend (2020 - YTD*2024)
- Figure 8: Novavax, Inc.: Partnership Trend by Deal Type (2020 - YTD*2024)
- Figure 9: Novavax, Inc.: Private Equity and Ownership Volume and Value Trend (2020 - YTD*2024)
- Figure 10: Novavax, Inc.: Private Equity and Ownership Volume by Deal Type (2020 - YTD*2024)
